Paul G. Fisher

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

Medicine, Immunology, Oncology +13

The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud

Katherine Wolstencroft, Robert Haines, Donal Fellows et al. · Nucleic Acids Research · 2013 · 682 citations · Full text

Life Sciences, Bioinformatics, Grid Computing +16

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · The Lancet Oncology · 2019 · 502 citations · Full text

Medicine, Oncology, Pediatrics +16

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Siddhartha S. Mitra, Abdullah H. Feroze, Jie Liu et al. · Science Translational Medicine · 2017 · 425 citations

Medicine, Immunology, Oncology +17

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

Michelle Monje, Siddhartha S. Mitra, Morgan E. Freret et al. · Proceedings of the National Academy of Sciences · 2011 · 345 citations · Full text

Medicine, Neuroscience, Oncology +17